CN114891822A - Construction method of high-yield gamma-linolenic acid mucor circinelloides recombinant bacteria, recombinant bacteria constructed by method and application - Google Patents
Construction method of high-yield gamma-linolenic acid mucor circinelloides recombinant bacteria, recombinant bacteria constructed by method and application Download PDFInfo
- Publication number
- CN114891822A CN114891822A CN202210762108.9A CN202210762108A CN114891822A CN 114891822 A CN114891822 A CN 114891822A CN 202210762108 A CN202210762108 A CN 202210762108A CN 114891822 A CN114891822 A CN 114891822A
- Authority
- CN
- China
- Prior art keywords
- mucor circinelloides
- delta
- strain
- recombinant
- gamma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000306281 Mucor ambiguus Species 0.000 title claims abstract description 72
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 title claims abstract description 58
- 235000020664 gamma-linolenic acid Nutrition 0.000 title claims abstract description 58
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 title claims abstract description 28
- 229960002733 gamolenic acid Drugs 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000010276 construction Methods 0.000 title claims abstract description 14
- 241000894006 Bacteria Species 0.000 title claims description 13
- 108010086283 delta-9 fatty acid desaturase Proteins 0.000 claims abstract description 16
- 239000013598 vector Substances 0.000 claims abstract description 16
- 108010037138 Linoleoyl-CoA Desaturase Proteins 0.000 claims abstract description 14
- 108010005155 delta-12 fatty acid desaturase Proteins 0.000 claims abstract description 13
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 9
- 230000001131 transforming effect Effects 0.000 claims abstract description 6
- 239000013604 expression vector Substances 0.000 claims abstract description 5
- 239000013612 plasmid Substances 0.000 claims description 23
- 238000000855 fermentation Methods 0.000 claims description 20
- 230000004151 fermentation Effects 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 210000001938 protoplast Anatomy 0.000 claims description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 230000002950 deficient Effects 0.000 claims description 2
- 230000010354 integration Effects 0.000 claims description 2
- 238000009629 microbiological culture Methods 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 23
- 229930195729 fatty acid Natural products 0.000 abstract description 23
- 239000000194 fatty acid Substances 0.000 abstract description 23
- 150000004665 fatty acids Chemical class 0.000 abstract description 23
- 238000012216 screening Methods 0.000 abstract description 5
- 239000002028 Biomass Substances 0.000 abstract description 4
- 238000010353 genetic engineering Methods 0.000 abstract description 2
- 108020004414 DNA Proteins 0.000 description 20
- 239000012634 fragment Substances 0.000 description 17
- 108090000623 proteins and genes Proteins 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 238000010586 diagram Methods 0.000 description 10
- 244000005700 microbiome Species 0.000 description 10
- 238000012258 culturing Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 108010044467 Isoenzymes Proteins 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 239000000600 sorbitol Substances 0.000 description 6
- 101710102786 ATP-dependent leucine adenylase Proteins 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 5
- 238000011144 upstream manufacturing Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- 241000235395 Mucor Species 0.000 description 4
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000002299 complementary DNA Substances 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 235000019157 thiamine Nutrition 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 239000011721 thiamine Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 239000007221 ypg medium Substances 0.000 description 3
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 102100020754 Putative fatty acid desaturase 2-like protein FADS2B Human genes 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000004186 co-expression Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000006372 lipid accumulation Effects 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940035893 uracil Drugs 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- 244000001632 Acorus gramineus Species 0.000 description 1
- 235000013073 Acorus gramineus Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 108050009160 DNA polymerase 1 Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 108090000301 Membrane transport proteins Proteins 0.000 description 1
- 102000003939 Membrane transport proteins Human genes 0.000 description 1
- 241000235575 Mortierella Species 0.000 description 1
- -1 Mucor Chemical compound 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- NGPGDYLVALNKEG-UHFFFAOYSA-N azanium;azane;2,3,4-trihydroxy-4-oxobutanoate Chemical compound [NH4+].[NH4+].[O-]C(=O)C(O)C(O)C([O-])=O NGPGDYLVALNKEG-UHFFFAOYSA-N 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 108010079058 casein hydrolysate Proteins 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 101150116440 pyrF gene Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 125000005480 straight-chain fatty acid group Chemical group 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/19—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/19—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
- C12Y114/19001—Stearoyl-CoA 9-desaturase (1.14.19.1), i.e. DELTA9-desaturase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/19—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water (1.14.19)
- C12Y114/19006—DELTA12-fatty-acid desaturase (1.14.19.6), i.e. oleoyl-CoA DELTA12 desaturase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/645—Fungi ; Processes using fungi
- C12R2001/785—Mucor
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a construction method of a high-yield gamma-linolenic acid mucor circinelloides recombinant strain, the recombinant strain constructed by the method and application, and belongs to the technical field of genetic engineering. The construction method of the high-yield gamma-linolenic acid mucor circinelloides recombinant strain comprises the steps of connecting nucleic acid sequences of delta 6, delta 12 and delta 9 fatty acid desaturase genes to an expression vector, transforming the obtained recombinant vector into a mucor circinelloides strain, screening positive clones, and allowing the delta 6, delta 12 and delta 9 fatty acid desaturase to be overexpressed in the mucor circinelloides strain, so as to obtain the high-yield gamma-linolenic acid mucor circinelloides recombinant strain. The recombinant strain Mc-d61d12d91 constructed by the method has the advantages that the GLA content is remarkably improved, the GLA content can reach 19.8% of total fatty acids, the oil yield is improved, the biomass can reach 38.2%, and the GLA yield can reach 1.22 g/L.
Description
Technical Field
The invention belongs to the technical field of genetic engineering, and particularly relates to a construction method of a high-yield gamma-linolenic acid mucor circinelloides recombinant strain, the recombinant strain constructed by the method and application.
Background
The microorganisms capable of accumulating more than 20% of oil in cells are called oil-producing microorganisms and comprise bacteria, fungi, yeast, microalgae and the like, the produced oil is microbial oil or unicellular oil, and the microbial oil has the advantages of high oil content, short production period, rich raw material source, no occupation of too much cultivated land, no influence of seasons and climate and the like. Since the 80 s in the 20 th century, the first strain in the world for realizing industrial production of GLA was the oil-producing microorganism Mucor circinelloides, and due to the strong lipid production capacity and complete genome sequencing, gene operation systems are increasingly perfected and used as model organisms for researching the production of GLA by microbial fermentation.
Polyunsaturated fatty acids (PUFAs) are straight-chain fatty acids with a carbon chain length of 18 to 22 carbon atoms, which contain two or more double bonds. PUFAs can be classified into two broad classes of polyunsaturated fatty acids, the omega-3 series and the omega-6 series, depending on where the double bond is first introduced. Linoleic acid, linolenic acid, and the like are called essential fatty acids because of the lack of enzymes that catalyze the production of two or more unsaturated double bonds in the human body.
GLA, an essential fatty acid, is an omega-6 series polyunsaturated fatty acid, has important physiological functions for human body, and has anti-inflammatory, anti-cardiovascular disease, anti-tumor and anti-diabetic effects. Currently, the main sources of GLA are some plant seeds, most of which are evening primrose, grass-leaved sweetflag, blackcurrant and the like. Because plant growth is greatly influenced by environment and the production period is long, more and more eyes are projected to microorganisms to produce GLA, such as Mucor, Mortierella, Benninghamella, Rhizopus, Trichoderma and the like, but at present, the GLA of both microorganisms and plant sources does not reach the yield of commercial production.
Disclosure of Invention
Aiming at the problems in the prior art, the invention aims to provide a construction method of a high-yield gamma-linolenic acid mucor circinelloides recombinant bacterium, the recombinant bacterium constructed by the method and application.
In order to achieve the purpose, the invention adopts the following technical scheme:
the construction method of the high-yield gamma-linolenic acid mucor circinelloides recombinant strain comprises the steps of connecting nucleic acid sequences of delta 6, delta 12 and delta 9 fatty acid desaturase genes to an expression vector, transforming the obtained recombinant vector into a mucor circinelloides strain, screening positive clones, and allowing the delta 6, delta 12 and delta 9 fatty acid desaturase to be over-expressed in the mucor circinelloides strain to obtain the high-yield gamma-linolenic acid mucor circinelloides recombinant strain.
In a specific embodiment, the nucleic acid sequence of the Δ 6 fatty acid desaturase gene is set forth in SEQ ID NO 1; the nucleic acid sequence of the delta 12 fatty acid desaturase gene is shown as SEQ ID NO. 2; the nucleic acid sequence of the delta 9 fatty acid desaturase gene is shown in SEQ ID NO. 3.
In a specific embodiment, the mucor circinelloidal strain is mucor circinelloidal Mu 760.
In a specific embodiment, the expression vector is at least one of an integrative plasmid pMAT2075 and an integrative plasmid pMAT 2076.
In a specific example, the Δ 6 fatty acid desaturase gene is first ligated to the integrative plasmid pMAT2075, and the recombinant plasmid is then transformed into the protoplast of mucor circinelloids deficient strain Mu760 to yield the recombinant strain Mc-d 61;
then the delta 12 fatty acid desaturase gene and the delta 9 fatty acid desaturase gene are connected to an integration plasmid pMAT 2076;
and finally, transforming the recombinant plasmid containing the delta 12 fatty acid desaturase gene and the delta 9 fatty acid desaturase gene into a protoplast of Mucor circinelloides Mc-d61 to obtain a recombinant strain Mc-d61d12d91, namely the constructed high-yield gamma-linolenic acid Mucor circinelloides recombinant strain.
The recombinant strain of the Mucor circinelloides for high yield of the gamma-linolenic acid constructed by the method is Mucor circinelloides, is preserved in China general microbiological culture Collection center (CGMCC 40013) at20 days 12 months in 2021, and has a preservation number of CGMCC 40013.
The application of the high-yield gamma-linolenic acid mucor circinelloides recombinant strain in fermentation production of gamma-linolenic acid.
A method for producing gamma-linolenic acid by fermenting the high-yield gamma-linolenic acid mucor circinelloides recombinant bacteria is to inoculate a strain with the preservation number of CGMCC 40013 on a fermentation medium for fermentation, wherein the fermentation condition is 28 ℃, 600rpm and the air input is 1v/v min -1 The pH was maintained at 6.0.
The technical scheme of the invention has the advantages that:
the invention provides a method for constructing a Mucor circinelloides strain with high GLA yield by coexpressing endogenous delta 6, delta 12 and delta 9 fatty acid desaturase genes; the GLA content of the recombinant strain Mc-d61d12d91 is remarkably improved to 19.8% of total fatty acid, the oil yield is also improved to 38.2% of biomass, and therefore the GLA yield can reach 1.22 g/L.
Drawings
FIG. 1 plasmid maps of pMAT2075, pCRC124, pMAT2076 and pCRC 150;
FIG. 2 is a diagram of the structure of the gene amplified by PCR of recombinant strain Mc-d61 and an electrophoretogram;
FIG. 3 shows a gene structure diagram and an electrophoretogram of PCR amplification of the recombinant strain Mc-d61d12d 91;
FIG. 4 Effect of isozymes of Δ 6 fatty acid desaturase on lipid content and GLA content;
FIG. 5 Effect of isozymes of Δ 9 fatty acid desaturase on lipid content and GLA content.
Detailed Description
Terms used in the present invention have generally meanings as commonly understood by one of ordinary skill in the art, unless otherwise specified.
The present invention will be described in further detail with reference to the following data in conjunction with specific examples. The following examples are intended to illustrate the invention and are not intended to limit the scope of the invention in any way.
Example 1
Cloning of mucor circinelloides des61, des12 and des91 and construction of recombinant vector
The Mucor circinelloides WJ11 strain was inoculated into a 500 mL baffled Erlenmeyer flask containing 100 mL of K & R medium, cultured at 28 ℃ and 130 rpm for 48 h, filtered with a Buchner funnel, and washed with distilled water three times to obtain a mycelium. Freezing at-80 deg.C overnight, extracting RNA by Trizol method, and reverse transcribing according to the reverse transcription kit instruction to obtain cDNA.
The extracted cDNA of the Mucor circinelloides WJ11 strain is taken as a template, and the following primer pairs are adopted to clone des61, des12 and des91 gene sequences shown as SEQ ID NO. 1, SEQ ID NO. 2 and SEQ ID NO. 3 respectively.
SEQ ID NO:1
SEQ ID NO:2
SEQ ID NO:3
The primer sequences for clones des61, des12 and des91 are as follows:
D61-F:5’–ATGAGCAGCGACGTAGGAGCAACAGC–3’(SEQ ID NO:4);
D61-R:5’–AGAAATTCAGCAAAAAAATGCTCTAA–3’(SEQ ID NO:5);
D12-F:5’–ATGATGGCAACCAAGAGAAACGTT–3’(SEQ ID NO:6);
D12-R:5’–TGTCTTCTTTAAGAACTAATCTATGA–3’(SEQ ID NO:7);
D91-F:5’–ATGTCAACTACAACGACAACTA–3’(SEQ ID NO:8);
D91-F:5’–AACCTGAGAAGAACAAGACCAAGTAA–3’(SEQ ID NO:9);
and (3) PCR reaction system: 5 XPrimeSTAR buffer 10. mu.L, dNTP mix (2mM each) 5. mu.L, upstream and downstream primers each 1. mu.L, total cDNA 100-200 ng, PrimeSTAR HS DNApolymerase 1. mu.L, ddH 2 Make up to 50. mu.L of O.
The reaction condition is that the cycle is started after the denaturation is carried out for 3min at 95 ℃, then the denaturation is carried out for 10min at 95 ℃, the annealing is carried out for 30sec at 55 ℃, the extension is carried out for 90sec at 72 ℃, the extension is continued for 10min at 72 ℃ after the cycle is carried out for 30 times, and finally the temperature is reduced to 4 ℃ for storage.
Recovering the amplified product, connecting the 1407bp des61 PCR fragment with pMAT2075 vector (vector diagram is shown as a in figure 1) to obtain pCRC124 (vector diagram is shown as b in figure 1), connecting the 1191bp des12 PCR fragment and the 1386bp des91 PCR fragment obtained by amplification with pMAT2076 vector (vector diagram is shown as c in figure 1) to obtain pCRC150 (vector diagram is shown as d in figure 1, pCRC150 is a plasmid containing des12 and des91 genes in the structural sequence of 1kb upstream of sodit-a, marker gene LeuA, promoter Pzrt1, target gene des12, terminator T1, promoter Pgpd1, des91 and 1kb downstream of sodit-a), then transferring the connected vector into competent cell E.coli Top10, coating the transformed product on a yeast strain containing 100mg/L penicillin (10g/L NaCl, 10g/L, 15 g/L) agar, placing the mixture in a constant temperature incubator at 37 ℃ for 14-16 h. And then selecting a single colony, inoculating the single colony into an LB liquid culture medium, culturing at 37 ℃ and 200rpm for 14-16 h, and extracting plasmids for sequencing verification.
Example 2
Obtaining of recombinant strain Mc-d61d12d91 of high-yield GLA mucor circinelloides
Preparation of Mucor circinelloides Mu760 protoplast: spores of Mu760 Mu circinelloides were inoculated onto YPG plates (3g/L yeast extract, 10g/L peptone, 20g/L glucose, 20. mu.g/mL leucine, 200. mu.g/mL uracil, pH 4.5) and cultured in a 28 ℃ incubator. Picking single colony to YPG plate, culturing at 28 deg.C for 3-4 days, collecting spore suspension, placing in sterilized 50mL centrifuge tube, calculating concentration by hemacytometer method, and diluting to obtain spore with concentration of 12.5 × 10 7 one/mL spore suspension, 1mL spore suspension was placed in a 250mL Erlenmeyer flask containing 20mL liquid YPG and left overnight at 4 ℃ to allow the spores to fully imbibe water and swell. The Erlenmeyer flask was then set to 28 ℃ and spores were cultured at 200rpm to germinate and observed microscopically for status. After centrifugation at 1500rpm for 5min, 5mL of PS Buffer pH6.5 (18.22g sorbitol and 20mL of SPB Buffer (10mM Na) 2 HPO 4 ,2mM KH 2 PO 4 ) Two washes) and YPG medium was washed off. Then, the cells were resuspended in 5mL of PS Buffer, and lyase was added to a final concentration of 4mg/mL and chitinase was added to a final concentration of 0.06. mu.L/mL, and the mixture was incubated at 30 ℃ for 90min in a shaker at 60rpm to remove cell walls. Then 20mL of 0.5M pre-cooled sorbitol is added, after centrifugation for 5min at 1500rpm, the mixture is washed twice by 0.5M pre-cooled sorbitol, 0.5M sorbitol is added to lightly blow and suck the heavy suspension precipitate to obtain protoplast, and the protoplast is subpackaged by 100 uL/tube for use.
Construction of recombinant strain Mc-d 61: 100 μ L of the above-prepared Mu760 protoplast of Mucor circinelloides was mixed with 1 μ g of plasmid pCRC124 and transformed by electric shock, 1mL of pre-cooled YPGS (0.5M sorbitol, 3g/L yeast extract, 10g/L peptone, 20g/L glucose) was added immediately after the electric shock was completed, incubated at 28 ℃ and 100rpm for 1h, centrifuged at 1500rpm to remove YPGS, and YNBS (91.1g/L sorbitol, 1.5g/L glutamic acid, 1.5g/L (NH) 4 ) 2 SO 4 0.5g/L yeast basic nitrogen source, 10g/L glucose, pH 4.5, adding thiamine and nicotinic acid to a final concentration of 1. mu.g/mL after sterilization, resuspending, uniformly coating on an MMC screening plate (10g/L casein hydrolysate, 0.5g/L yeast basic nitrogen source, 20g/L glucose, 15g/L agar, pH 3.2, adding thiamine and nicotinic acid to a final concentration of 1. mu.g/mL after sterilization), and avoiding temperature at 28 ℃ to avoidAnd (5) performing light culture for 3-4 days. Randomly picking single colony hypha on a new MMC plate, culturing for 2-3 days at 28 ℃, collecting spores, respectively inoculating about 200 spores into the MMC plate and the MMC plate containing uracil, culturing for 2-3 days at 28 ℃, counting, repeating the screening steps until the growth number of the spores in the two plates is basically the same, and indicating that a transformant with stable heredity is obtained. Stably inherited transformant is cultured on YPG medium plate at 28 ℃ for 5-7 days to collect spores, and the concentration of the spores is adjusted to be 1 multiplied by 10 7 pieces/mL were stored in 30% glycerin tube at-80 ℃. The finally obtained recombinant strain Mc-d61 of Mucor circinelloides and the control strain Mc-2075 (pMAT 2075-unloaded strain) were verified by PCR using the following primer pairs.
CarRP-F:5’–GATAAGCATA AACCAGATCTGC–3’(SEQ ID NO:10);
CarRP-R:5’–GTATCTGACA TAGTCGAGCTTC–3’(SEQ ID NO:11);
The reaction system and the amplification condition are pre-denatured at 95 ℃ for 2min, denatured at 98 ℃ for 20sec, annealed at 51 ℃ for 20sec, extended at 72 ℃ for 3min and 30sec, extended at 72 ℃ for 7min after 30 cycles, and finally cooled to 4 ℃ for storage.
The PCR results are shown in FIG. 2, wherein a is the gene structure diagram of the different amplified strains, 1 is the CarRP gene segment of the original strain Mucor circinelloides Mu760, 2 is the genomic fragment obtained by transferring PyrF and Pztt 1 of the empty plasmid pMAT2075 into Mucor circinelloides Mu760 by using the principle of homologous recombination, and 3 is the genomic fragment obtained by transferring the plasmid fragment with over-expressed d61 into Mucor circinelloides Mu 760. Wherein, the fragment obtained by amplifying the recombinant strain Mc-d61 of the Mucor circinelloides is 5887bp, and the fragment of the corresponding position of the control strain Mc-2075 is 4476bp, which indicates that the recombinant plasmid is successfully transformed into the Mucor circinelloides. b is an electrophoresis result picture of amplification, wherein M is maker; lane 1 is control strain Mc-2075; lanes 2 and 3 represent the recombinant strain Mc-d61 of Mucor circinelloides, which is consistent with the results in a.
Construction of recombinant strain Mc-d61d12d 91: preparing protoplast from recombinant strain Mc-d61 by the above method, mixing 100uL of Mc-d61 protoplast with 1 μ g of plasmid pCRC150, performing electric shock transformation, immediately adding 1mL of precooled YPGS, incubating at 28 deg.C and 100rpm, and culturingYPGS was removed by centrifugation at 1500rpm for 1h, resuspended in YNBS and plated onto YNB selection medium (1.5g/L glutamic acid, 1.5g/L (NH) 4 ) 2 SO 4 0.5g/L yeast basic nitrogen source, 10g/L glucose, 15g/L agar and pH 3.2, adding thiamine and nicotinic acid to a final concentration of 1 mu g/mL) after sterilization, and culturing for 3-4 days at 28 ℃ in the dark. Randomly picking single colony hyphae on a new YNB plate, culturing for 2-3 days at 28 ℃, collecting spores, respectively inoculating about 200 spores into the YNB plate and the YNB plate containing leucine, culturing for 2-3 days at 28 ℃, counting, and repeating the screening steps until the growth number of the spores in the two plates is basically the same, which indicates that genetically stable transformants are obtained. Stably inherited transformant is cultured on YPG medium plate at 28 ℃ for 5-7 days to collect spores, and the concentration of the spores is adjusted to be 1 multiplied by 10 7 pieces/mL were stored in 30% glycerin tube at-80 ℃. Finally, the recombinant strain Mc-d61d12d91 of the mucor circinelloides is obtained. PCR validation was performed using the following primer pairs.
mt-F:5’–TTATTTTTATCGTTTGGTGGTACACAAACTGC–3’(SEQ ID NO:12);
mt-R:5’–GTAACCCCACAGAAATAGAGCCATAAGG–3’(SEQ ID NO:13);
The reaction system and the amplification condition are pre-denatured at 95 ℃ for 2min, denatured at 98 ℃ for 20sec, annealed at 50 ℃ for 20sec, extended at 72 ℃ for 5min, extended at 72 ℃ for 10min after 30 cycles, and finally cooled to 4 ℃ for storage.
The PCR verification result is shown in FIG. 3, a is the gene structure diagram of different amplified strains, 1 is the structure diagram of the amplified fragment of the recombinant strain Mucor circinelloides Mc-d61, and 2 is the structure diagram of the amplified fragment of the recombinant strain Mc-d61d12d 91; wherein, the fragment obtained by amplifying the recombinant strain Mc-d61d12d91 of the Mucor circinelloides is 9980bp, while the fragment of the corresponding position of the control strain Mc-d61 is 4217bp, which indicates that the plasmid is successfully transformed into the Mucor circinelloides. b is an electrophoresis result picture of amplification, wherein M is maker; lane 1 is control strain Mc-d 61; lanes 2 and 3 represent the recombinant strain Mc-d61d12d91 of Mucor circinelloides, which is consistent with the results in a.
The successfully constructed recombinant strain Mc-d61d12d91 was deposited in the general microbiological center of the China Committee for culture Collection of microorganisms at 12 months and 20 days in 2021, and the address is No. 3 Hospital No. 1 of Xilu, North Chen, the sunward, Beijing, City. The preservation number given to the biological material by the collection center is CGMCC 40013, and the suggested classification name is Mucor circinelloides.
Example 3
Fermentation method of recombinant strain Mc-d61d12d91 of high-yield GLA mucor circinelloides
In a 1.5L fermenter with 1L K&And culturing the recombinant strain Mc-d62d12d91 of the mucor circinelloides in the culture medium R. The fermentation conditions were 28 ℃, 600rpm, and the air input was 1v/v min -1 The pH was maintained at about 6.0.
K&R medium: 30g/L glucose, 1.5g/L MgSO 4 ·7H 2 O, 3.3g/L ammonium tartrate, 7.0g/L KH 2 PO 4 ,2.0g/L Na 2 HPO 4 1.5g/L yeast extract, 0.1g/L CaCl 2 ·2H 2 O,8mg/L FeCl 3 ·6H 2 O,1mg/L ZnSO 4 ·7H 2 O,0.1mg/L CuSO 4 ·5H 2 O,0.1mg/L Co(NO 3 ) 2 ·6H 2 O,0.1mg/L MnSO 4 ·5H 2 O。
Collecting fermentation liquor samples of 6, 12, 24, 48, 36, 48, 60, 72, 84 and 96 hours according to the oil production rule of mucor circinelloides, separating the fermentation liquor and mycelium, storing the fermentation liquor at-20 ℃ for later use, washing the mycelium for 3 times by using distilled water, collecting the mycelium, storing at-80 ℃, and then freezing and drying for later use.
The method for extracting the grease in the sample comprises the following specific steps: weighing about 10mg of the freeze-dried thalli, and adding 2mL of 4M hydrochloric acid into a 5mL glass bottle; ② water bath is carried out for 3h at 80 ℃, and vortex oscillation is carried out once every 30 min; ③ cooling to room temperature, adding 1mL of methanol and 1mL of chloroform, and adding 100 μ L of pentadecanoic acid (C15: 0) with a certain concentration as an internal standard by using a microsyringe; fourthly, fully and uniformly mixing for 15min, centrifuging for 5min at 3000rpm, and collecting a chloroform layer in a new glass bottle; drying by nitrogen; sixthly, adding 1mL of 10% hydrochloric acid methanol solution, carrying out water bath at 60 ℃ for 3h, and carrying out vortex oscillation once every 30 min; seventhly, after cooling to room temperature, adding 2mL of n-hexane and 1mL of saturated saline solution, fully and uniformly mixing for 15min, centrifuging at 3000rpm for 5min, sucking 1mL of the upper n-hexane layer, and transferring to a gas phase bottle to obtain a fatty acid methyl ester solution.
Adopting gas chromatography analysis, wherein the gas chromatography is GC-689N of Agilent in America, and the measurement conditions are as follows: gas chromatography conditions, no split-flow sample injection, DB-Waxetr (30m × 0.32mm, 0.22 μm) chromatographic column, hydrogen ion flame monitor, nitrogen as carrier gas, 250 ℃ for both gasification chamber temperature and detector temperature, and 1 μ L sample injection. Temperature rising procedure: the initial temperature is 80 ℃, the temperature is increased to 200 ℃ at the heating rate of 8 ℃/min, then increased to 205 ℃ at the heating rate of 1 ℃/min, finally increased to 240 ℃ at the heating rate of 4 ℃/min, and the temperature is kept for 5 min. The position of each fatty acid and the size of the peak area of the composition are recorded, and the total fatty acid content is calculated. As a result, as shown in Table 1, the intracellular lipid content of the overexpression strain Mc-d61d12d91 was significantly increased as compared with the control strain Mc-2075.
TABLE 1 oil and fat content of control and overexpression strains Mc-d61d12d91
The results of the measurement of the intracellular fatty acid composition of the recombinant strain Mc-d61d12d91 are shown in Table 2, and it can be seen from Table 2 that the intracellular fatty acid composition of the recombinant strain Mc-d61d12d91 is greatly changed and the GLA content is increased to 19.8% of the total fatty acids compared with the control strain Mc-2075.
TABLE 2 fatty acid composition and amount of Mc-d62d12d91 for control and over-expressed strains
Effect of isoenzymes on oil and fat content and GLA content
Both Δ 6 and Δ 9 fatty acid desaturases have two isoenzymes. Δ 61 was more effective than Δ 62 for both isozymes of Δ 6 fatty acid desaturase. Delta 61 and delta 62 genes were ligated into the pMAT2075 vector, respectively, to transform the Mucor circinelloides strain Mu760 to obtain over-expressed strains (Mc-d61 and Mc-d62) containing delta 61 and delta 62, and to transform a pMAT 2075-unloaded strain as a control (Mc-2075); after fermentation for 96h in a 1L fermentation tank, the contents of lipid and various fatty acids were measured by oil extraction, and the results are shown in FIG. 4, wherein the GLA content of the Mc-d61 strain is 21% in total fatty acid content, which is 61.5% higher than that of the control strain (13%), while the GLA content of the Mc-d62 strain is only 15.7% in total fatty acid content, which is not significantly changed compared with the control strain.
Δ 91 is more effective than Δ 92 for both isozymes of Δ 9 fatty acid desaturase. Respectively connecting delta 12, delta 91, delta 12 and delta 92 into a pMAT2076 vector, transforming the Mc-d61 strain to obtain two recombinant strains of Mc-d61d12d91 and Mc-d61d12d 92; the transformed pMAT 2075-unloaded strain was used as a control (Mc-2075); after fermentation for 96h in a 1L fermentation tank, the contents of lipid and various fatty acids are measured by extracting oil, and the results are shown in FIG. 5, the total fatty acid content of the fermentation recombinant strain Mc-d61d12d91 reaches 38.2%, the content of GLA in the total fatty acids reaches 19.8%, the yield of GLA is remarkably improved to 1.22g/L, the total fatty acid content of the fermentation recombinant strain Mc-d61d12d92 reaches 36%, the content of GLA in the total fatty acids is 13.2%, and the yield of GLA is 0.72g/L (see FIG. 5).
Taken together, a single overexpression of Δ 61 and Δ 62, Δ 61 resulted in a 21% GLA proportion of total fatty acids higher than Δ 62, but the total fatty acid content and biomass did not change significantly compared to the control, so that GLA production was not as high for the Δ 61 overexpressing strain (Mc-d 61). Later, three genes (Mc-d61d12d91) of delta 61 delta 12 delta 91 were co-expressed, and the proportion of GLA in the total fat was slightly reduced (19.8%) but the GLA yield was significantly increased (high total fatty acid content) due to the significant increase in the total fatty acid content. The co-expression of a plurality of desaturase genes increases the total fatty acid content, the proportion of single fatty acid is reduced, but the yield combines the three factors of the proportion of GLA, the total fatty acid content and biomass, so that the co-expression of the three genes remarkably increases the GLA yield.
In the above embodiment:
the pMAT2075 is constructed as described in the Improved SDA production in high lipid accumulating strain of Mucor circinelloides WJ11by genetic modification;
pMAT2076 is the upstream and downstream 1kb of sodit-a which replaces CarRP homologous arm of pMAT2075, and the replacement marker gene pyrF is LeuA, namely, pMAT2076 is constructed; the specific method comprises the following steps:
using genome DNA of WJ11 as a template, designing an upstream primer F1/R1 containing SphI and SnaBI enzyme cutting sites, obtaining a sodit-a gene fragment through PCR, using SphI and SmaI to cut a pUC18 vector, then using T4DNA ligase to connect the sodit-a gene fragment with the enzyme cutting fragment of a pUC18 vector to obtain pUC 18-sodata-up-down, using the pUC18 vector as the template, designing an upstream primer F2/R2 containing XbaI and NheI enzyme cutting sites, using PCR to obtain linearized pUC18 and sodata-pUC up/down fragments, using Suzhou Jinzhi Biotech limited to synthesize a LeuA and Pztt 1 connected fragment (SEQ ID NO:18), also using NheI and XbaI to cut a LeuA and Pzsort 1, and then using T4DNA ligase to connect the LeuA and Pzsortit 1 with linearized DNA 18 and Pzta plasmid 2076/up.
The Mucor circinelloides WJ11 strain is Mucor circinelloides with the preservation number of CCTCC NO: M2014424;
the strain Mucor circinelloides Mu760 is a strain existing in the laboratory, and Deletion of plasmid Membrane Transporters introduced Lipid Accumulation in the filed of literature has been reported as Deletion of microorganism circulating microorganisms WJ11 and Improved SDA production in high Lipid Accumulation strain of microorganism circulating microorganisms WJ11by genetic modification.
F1:5’–CGATGGCATGCCCGGGGCGTATGGGCCCTTATGATATCACAC–3’(SEQ ID NO:14);
R1:5’–CTGCATACGTACCCGGGGTTACATTAGCAGGTATTTTTGC–3’(SEQ ID NO:15);
F2:5’–CCCGAGCTAGCCTCGAGCCAGATACTGTACTTCCACTTTTTAC–3’(SEQ ID NO:16);
R2:5’–CGTACTCTAGATTTGTATACAAAGTGAAAGAAAGATG–3’(SEQ ID NO:17);
SEQ ID NO:18
The foregoing is directed to preferred embodiments of the present invention, other and further embodiments of the invention may be devised without departing from the basic scope thereof, and the scope thereof is determined by the claims that follow. However, any simple modification, equivalent change and modification of the above embodiments according to the technical essence of the present invention are within the protection scope of the technical solution of the present invention.
Sequence listing
<110> university of Shandong's science
Construction method of high-yield gamma-linolenic acid mucor circinelloides recombinant bacteria, recombinant bacteria constructed by method and application
<160> 18
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1407
<212> DNA
<213> Mucor circinelloides (Mucor circinelloides)
<400> 1
atgagcagcg acgtaggagc aacagcagta ccccattttt atactcgtgc tgaattggct 60
gatatccatc aagatgttct ggacaagaaa cctgaagcta gaaaactaat tgtcgtcgag 120
aataaggtat acgatatcac agatttcgta tttgatcacc ctggcggtga gcgagtactt 180
ttgactcaag agggcagaga cgctacagat gtctttcatg aaatgcatcc tccctctgct 240
tacgaattgc tggcgaattg ctatgttggc gattgtgagc ccaagctgcc tatcgattca 300
accgataaga aggcattgaa ttctgctgct tttgctcaag aaattcgtga tctccgagat 360
aaattagaaa aacaaggcta tttcgacgct agtactggtt tctacatcta taaagtttcc 420
actaccctac ttgtctgtat tgtaggttta gctatcctca aagcttgggg tagagagtct 480
actttggctg tgtttattgc tgcttcttta gttggtcttt tttggcagca gtgcggttgg 540
cttgcccatg attatgctca ctatcaagtc atcaaagacc ccaatgtcaa taatctcttt 600
ttagttactt ttggcaacct ggttcaaggt ttctctcttt catggtggaa aaacaagcac 660
aatacccacc acgctagcac caatgtctct ggcgaagatc ccgatatcga tactgccccc 720
attttgctat gggacgagtt tgcagccgct aatttctatg gatccttgaa ggacaatgcc 780
agtggatttg acagattcat tgctgaacac attttgccct atcaaactcg ttactacttc 840
ttcattcttg gtttcgctcg tacctcttgg gctatccaat ctattatcta ttccttcaag 900
aacgaaacat tgaataaatc aaagctcttg tcctggtgtg agcgcatctt tttgattgtt 960
cattgggtct ttttcactta ctgcactatt gcctggatca gctctatcag aaacatcgcc 1020
atgttctttg ttgttagcca aatcactact ggttacttgc tcgccatcgt ctttgctatg 1080
aaccataatg gcatgcctgt ttacagcccc gaagaagcaa accataccga gttttatgaa 1140
ttgcaatgta tcactggtcg cgatgtcaac tgcactgtat ttggcgattg gctcatgggt 1200
ggattgaatt atcaaattga gcaccatctt ttccccgaaa tgcctcgaca tcatttatcc 1260
aaggtgaaat ccatggtcaa acccattgct caaaagtata atatccctta ccatgatacc 1320
acagtcattg gtggtaccat tgaagtcttg caaaccttgg attttgttca aaagatttcg 1380
cagaaattca gcaaaaaaat gctctaa 1407
<210> 2
<211> 1191
<212> DNA
<213> Mucor circinelloides (Mucor circinelloides)
<400> 2
atggcaacca agagaaacgt tacctccaat gctcctgctg cagaagacat cagcatcagc 60
aacaaggctg tgattgatga agccattgaa agaaactggg agatccccaa tttcaccatc 120
aaggagatcc gtgatgctat cccagctcac tgtttccgtc gtgatacctt tagatccttt 180
acacatgttc ttcatgatat tatcatcatg tccatcttgg ccattggtgc ttcttacatt 240
gattccatcc ctaataccta tgctcgcatt gctctctggc ccttgtactg gatcgctcaa 300
ggtattgttg gcactggtgt ctgggtcatt ggtcatgaat gtggccatca agcattcagc 360
ccttcaaaga ctatcaataa tagcgttggt tacgttctcc acactgcttt attagtacct 420
tatcactcat ggagattctc tcactctaag catcataaag ccactggaca catgtcaaaa 480
gatcaggtct ttgtcccctc tactcgtaag gaatacggtt tgcctcctcg tgagcaagat 540
cctgaagttg atggacctca tgatgctctt gatgaagctc ccatcgttgt cttgtatcgc 600
atgttccttc aatttacctt tggctggcct ctttatctct tcaccaatgt ctctggtcaa 660
gattaccccg gttgggcttc tcatttcaac cccaagtgtg ctatctacga tgaaaaccaa 720
ttctgggatg ttatgagctc caccgctggt gtccttggca tgattggttt cttggcttac 780
tgtggtcaag tctttggctc tcttgctgtc atcaagtact atgttattcc ctatttgaat 840
gttaactttt ggttggttct aatcacttac ttgcaacaca ctgatcccaa gttgcctcat 900
taccgtgaaa atgtttggaa cttccaacgc ggtgctgctt taactgttga tcgttcttat 960
ggtttcctcc tcgactactt ccatcatcac atttctgaca ctcatgttgc tcaccatttc 1020
ttctccacca tgcctcacta ccacgctgaa gaagctactg ttcatatcaa gaaggctctt 1080
ggtaagcact accactgcga caacactcct gtccctatcg ccttgtggaa ggtctggaag 1140
agttgccgtt ttgttgaaga tgagggcgat gttgtcttct ttaagaacta a 1191
<210> 3
<211> 1386
<212> DNA
<213> Mucor circinelloides (Mucor circinelloides)
<400> 3
atgtcaacta caacgacaac tacaacacaa gtaaacgctg acggaaagta tcctccttat 60
gcttacacac agactgagga tcgtcaactt cctttggcca atcctaagat gccccctttg 120
tttgatgaac ctactacact ccagaatttt gtcagccatg tcaactggtt ccaatccatt 180
ctcttgattt caacacctct tttgggtatc tatcttgcct ccaagactga attgcaaaca 240
aagacattgt actgggcaat cacctattac ttgatcactg gtttaggtat cactgctggt 300
taccatcgct actggtccca tagatcctat gattgtacct tacctactcg cattgctctt 360
tgcttggctg gttctggtgc cttccaaggc tctattcatt ggtggtcccg tggacatcgt 420
gctcatcatc gttggactga ttctgacaaa gatccttatg ctgctcctcg tggtttcttc 480
ttttctcata ttggttggat gttgattaac agacccaaga acagaattgg atatgctgat 540
actgctgatc ttaaggctga cccacttgtc cgtttccaac acaagaatta catttatttc 600
gctgtattta tggcttttgc tttccctacc ttagttgctg gcctcttgtg gggtgactgg 660
aagggtggtt tcgtttttgc tggcctctgt cgtcttgttg ccattcatca tgctactttc 720
tgtgtcaata gtcttgctca ttacattggc gacactcctt atgatgatta tcacactccc 780
aaagattctt ggatcactgc cattgttacc tgcggtgaag gttaccacaa tttccaccat 840
gaattccctc aagattatcg taacgctatt ctttggcacc aatacgatcc tacaaaatgg 900
ctcattagag gtttaagttt cattggtcaa acatacaact taaagacttt ctctgccaac 960
gagattcaaa agggcaaggt tcaaatgatg gaaaagaagg ctgacgagat caagaaaaca 1020
cttagttttg gtaagacact tgctgaattg cctgtctata ctatggaaga attccatgcc 1080
aaggtgaaca atgaggataa gaagtgggtt cttttggacg gcatcatgta cgacgttgag 1140
aactttgacc atcctggtgg agccaagtat ctcaatgctg gtattggcaa agatatgacc 1200
aagtcgttca atggcggtat ctacaatcat tcaaacggtg ctcgtaactt gctctctagt 1260
atgcgtgtcg gtgtgctcaa aggtgctatt gacatgaacc gtaatttctc aaagactgaa 1320
gcctctcaag aaaagtgtgc tgaatatgat ggtactctgg aacctgagaa gaacaagacc 1380
aagtaa 1386
<210> 4
<211> 26
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
atgagcagcg acgtaggagc aacagc 26
<210> 5
<211> 26
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
agaaattcag caaaaaaatg ctctaa 26
<210> 6
<211> 24
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
atgatggcaa ccaagagaaa cgtt 24
<210> 7
<211> 26
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
tgtcttcttt aagaactaat ctatga 26
<210> 8
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
atgtcaacta caacgacaac ta 22
<210> 9
<211> 26
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
aacctgagaa gaacaagacc aagtaa 26
<210> 10
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
gataagcata aaccagatct gc 22
<210> 11
<211> 22
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 11
gtatctgaca tagtcgagct tc 22
<210> 12
<211> 32
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 12
ttatttttat cgtttggtgg tacacaaact gc 32
<210> 13
<211> 28
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 13
gtaaccccac agaaatagag ccataagg 28
<210> 14
<211> 42
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 14
cgatggcatg cccggggcgt atgggccctt atgatatcac ac 42
<210> 15
<211> 40
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 15
ctgcatacgt acccggggtt acattagcag gtatttttgc 40
<210> 16
<211> 43
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 16
cccgagctag cctcgagcca gatactgtac ttccactttt tac 43
<210> 17
<211> 37
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 17
cgtactctag atttgtatac aaagtgaaag aaagatg 37
<210> 18
<211> 4330
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 18
gtacgtctag aaaattcagt gagatgcttt ttctacagta tcaatagttt atttccataa 60
cccattcaac tccatgtatc caggcaagaa atcaaaaacg aacaattaca gctgtctgat 120
ctaggtaatg tgcatggatc caagtgacca tgtatgtaaa agtttctatg gtggaaaatg 180
atcaatgcat atttctctac ggaatatctg cgaatgaaat gtgcaaagtc attaatcgtt 240
ctacatttga tgctttatga ctgaaccctc aattgaaatt cacccagaaa aagctcatga 300
tcttcatgtt cctctttact ttgcagattt gttttgaatg gtgatttgaa aggagtggga 360
aaaagaatct ccagcgttta cgttacatgg aaaaaagaga gttaggccaa taggagcaca 420
acgcctcatt gagtcactgc cagttcaagc agtttgtggt cggatctgta aattgacagg 480
caatcaagac gcctgagtca ctatactact tgtgccaagt tggtgagatt gaccaatgat 540
ttcatcaatc tcattgagtc aggataaatg caaatattta ctttataata acctgctaac 600
aaacgaggat tttcttattt ctttaacttg tttcttacat ttttaaaaaa taaataaccc 660
cctccaatta tatacaaatg tctcgcactc tctatgataa agtctgggat gatcatgtca 720
ttgatcaaca agaagatggt acttgtttga tctatatcga tagacatctt gtgcatgaag 780
tcactagtcc tcaagctttc gaaggccttc gcaatgccaa ccgtccagta cgtcgtcctg 840
actgtactct tgctactgtc gatcacaaca ttcctactac aaccagaaag aatttcaaaa 900
atatcaccac tttcatcaaa gaagctgatt caagaactca atgtgagact cttgaacaaa 960
acatagaagc ctttggtctt acctatttcg gtatggagga tagtcgtcaa ggtattgtac 1020
atgttattgg tcctgagcaa ggttttactc tccccgcaac tactgttgta tgcggtgatt 1080
cacatacatc tacacacggt gcttttggtg cccttgcttt tggtattggt acatccgaag 1140
tagagcatgt acttgctacc caaactctct tacaaaagaa gtcaaagaac atgcgcattc 1200
gcgttcaagg taaagccctt cccggcgtca catccaagga tattgttctt cacattattg 1260
gtgttattgg tactgctggt ggtaccggtt gtgttattga attctgtggt gatactattg 1320
ctgctctctc catggagtca agaatgtcca tctgtaacat gtcaattgaa gcgggtgctc 1380
gtgctggtat ggttgctccc gatgaggtta cctttgaata ccttcgtgat aaacctctcg 1440
ctcccaaggg cgctgattgg gatcgtgctg tcaaatattg gaagtctctc agctctgatg 1500
ccgacgccaa gtacgatatt aacgtagaaa ttaacgctgc tgacattgct cctactctta 1560
cctggggtac tagtcctcaa gatgtcgttc ctattactgg ttcaactcct gatcctgcaa 1620
agattgagga tcccattcgt cgttctgctg ttcaacgtgc tcttgactat attggtattg 1680
ctcccaacac tcctatggaa ggtgtcaagg tggacaaggt atttatcggt agttgtacca 1740
actctcgtat cgaggatctt cgtgctgctg ctgctgtagt caagggtaag cgtgctgctg 1800
aatgggttga tgccatggtg gttcctggtt caggtttggt taaacgtcaa gctgagcgtg 1860
aaggtttaga caagatcttc actgatgctg gttttgattg gagagaggct ggttgttcca 1920
tgtgtctcgg catgaaccct gatcaattga agcctggaga acgttgtgca tctacatcta 1980
atcgtaattt tgagggtcgt caaggtgctg gtggacgtac tcatcttgta agccctgcca 2040
tggctgctgc tgctggtatc aagggttgtc ttactgatgt ccgtaacatg gaagtctctg 2100
aaattcctgg tactcccaag caaagtcctc gtcaagaagt tgttgccgaa ttcgagtctg 2160
aagatgaagt cgattccagc tctgttgatt ctgctactgt tgctacacct cctagcactg 2220
gcgagtctgc tggtatgccc aagttcacta ctctcaaggg ctatgctgct cctcttgata 2280
tctctaatgt cgatactgat atgattattc ccaagcaatt cctcaagacc atcaaacgca 2340
ctggccttgg tagtgctctt ttctatgctc tccgtttcga ccctactact ggcgctgaga 2400
accctgactt tgtcctcaac caagaaccct atcgtcaagc ccgtaccttg gtttgtactg 2460
gtcccaactt tggctgtggt agttctcgtg aacatgctcc ttgggccttt aacgactttg 2520
gtatccgttg tatccttgca cctagttttg cagatatttt ctataacaac tgcttcaaga 2580
atggtatgct ccccattgtc cttcctcaag atcaattaga agctattgct gctgaagcta 2640
agaagggatc cgaagttgaa gtggacctta tcaatcaagt tgttcgtttt gccggcaatg 2700
aagttccttt tgaagtggag gctttccgta agcactgcct tgtcaatggc tttgatgaca 2760
ttggattgac tatgcaaaag gctgacaaga ttgctgattt cgaggtcaag cgcactgaaa 2820
catggccttg gttaaatgga aagggttata agggaaaggc taccaaaatc tctatcaacg 2880
gtgaaggtca aaagaagaag accaagctcg attggtaatt attgtaataa aacacttatt 2940
ttattgtaac tctattattt cctgtttcat atttcgatct attcattctc ttatcatatt 3000
ttaattttat taatcacatt ttaaataaat tgcattccct ctctttatat acaattcact 3060
gcttgtctag taatgcttga tattgttttg tgcctgatac gttgggcgtg tgacagacaa 3120
acaccaaaat gcccaaattt ctcgactgtt taaaagttta gcttctttct tcaacacgat 3180
gctgttcaac actagtgttg ttgctggata ctttagcctt cttccgttaa tcatactgta 3240
cactgatggc tatatagaaa agactctaat atacttgcat gctcttggca tcacttgtat 3300
tttgtatatt ctggtaaatt cgacaagtga tgagacaacg acgacgacag atgcatacaa 3360
gtctaattta cactgatgaa ccatcaatac attgtactat gatacagaaa aggattcctg 3420
atatcatata agcagcttta gttacgacct atttttgaga cactgctatg agtactaaca 3480
atcatcgctc taatgggtag cacgttgcac ttgcaagcgg ctgccaaaat atataaaagc 3540
gtagaatgtc ttcactaatc caatgtgcaa tcattagata tgtactacac aagatgtaga 3600
aatcaagatt acagaaattc attgctcatc acatcagcaa accacggcat ttagagcgct 3660
aggccatcaa cctaaactca aaaatttctg cgggatcaca atgctcgttt catatagaaa 3720
attttgccct gataggaaca ttctgtatga gctgtaacct caaaaatttt tagtcttgcg 3780
cactatgtat agcccatggc gtatcattgc ctcatacaat acatgtctag cagcttcccg 3840
cctaaccacc actgaaactc tacacattag tgctctttta attagacagg ctgccatagc 3900
aacgtcctaa actgtgatgt aatatgtaat tcataagaaa tttttgatat ttttaaacat 3960
catctcactc aaatggtgct actttcaatt gcttgaaatg gaagtatttc aggtctgaaa 4020
ccttctcatc aactgaaaat cctcggcgtc atgatgtttt tgtgtacctt gagggtgata 4080
ttttgacctt gtcgtgacta aatattagaa atttttggca ttgattggct gtatgtcacc 4140
ttgaaggtac taaaactatg tgtaccttat ccgttacctg atctttggga ggagatgtgc 4200
cttgatgata tgctctacgt tggtttcaag tcattatttg tataaataga ccaagagaag 4260
gctttactgt tcctatcatt ctttgctttc tattactttt atatacaaaa taactaaata 4320
gatctcatgc 4330
Claims (8)
1. The construction method of the high-yield gamma-linolenic acid mucor circinelloides recombinant strain is characterized in that nucleic acid sequences of delta 6, delta 12 and delta 9 fatty acid desaturase genes are connected to an expression vector, the obtained recombinant vector is transformed into a mucor circinelloides double-defect strain, positive clones are screened, delta 6, delta 12 and delta 9 fatty acid desaturase is overexpressed in the mucor circinelloides double-defect strain, and the high-yield gamma-linolenic acid mucor circinelloides recombinant strain is obtained.
2. The construction method of the recombinant bacteria of the Mucor circinelloides for high yield of gamma-linolenic acid according to claim 1, characterized in that the nucleic acid sequence of the delta 6 fatty acid desaturase gene is shown as SEQ ID NO. 1; the nucleic acid sequence of the delta 12 fatty acid desaturase gene is shown as SEQ ID NO. 2; the nucleic acid sequence of the delta 9 fatty acid desaturase gene is shown in SEQ ID NO. 3.
3. The method for constructing the recombinant strain of the Mucor circinelloides for high yield of gamma-linolenic acid according to claim 1, wherein the strain with double-defect type of Mucor circinelloides is Mu 760.
4. The method for constructing the recombinant bacteria of the mucor circinelloides with high yield of gamma-linolenic acid according to claim 1, wherein the expression vector is at least one of an integrative plasmid pMAT2075 and an integrative plasmid pMAT 2076.
5. The construction method of the high-yield gamma-linolenic acid Mucor circinelloides recombinant strain according to any one of claims 1 to 4, characterized in that,
connecting the delta 6 fatty acid desaturase gene to an integrative plasmid pMAT2075, and then transforming the recombinant plasmid into a protoplast of a mucor circinelloides defective strain Mu760 to obtain a recombinant strain Mc-d 61;
then the delta 12 fatty acid desaturase gene and the delta 9 fatty acid desaturase gene are connected to an integration plasmid pMAT 2076;
and finally, transforming the recombinant plasmid containing the delta 12 fatty acid desaturase gene and the delta 9 fatty acid desaturase gene into a protoplast of Mucor circinelloides Mc-d61 to obtain a recombinant strain Mc-d61d12d91, namely the constructed high-yield gamma-linolenic acid Mucor circinelloides recombinant strain.
6. The high-yield gamma-linolenic acid Mucor circinelloides recombinant strain constructed by the method of claim 4 is characterized in that the recombinant strain is Mucor circinelloides (Mucor circinelloides), and the strain is preserved in the China general microbiological culture Collection center (CGMCC 40013) at 12-20 months in 2021 with the preservation number of CGMCC 40013.
7. The use of the recombinant bacteria of mucor circinelloides for producing gamma-linolenic acid with high yield according to claim 6 in the fermentation production of gamma-linolenic acid.
8. A method for producing gamma-linolenic acid by fermenting the high-yield gamma-linolenic acid mucor circinelloides recombinant strain as claimed in claim 6 is characterized in that a strain with the preservation number of CGMCC 40013 is inoculated on a fermentation medium for fermentation, the fermentation condition is 28 ℃, the rpm is 600, and the air input is 1v/v min -1 The pH was maintained at 6.0.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210762108.9A CN114891822B (en) | 2022-06-29 | 2022-06-29 | Construction method of high-yield gamma-linolenic acid mucor circinelloides recombinant bacterium, recombinant bacterium constructed by method and application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210762108.9A CN114891822B (en) | 2022-06-29 | 2022-06-29 | Construction method of high-yield gamma-linolenic acid mucor circinelloides recombinant bacterium, recombinant bacterium constructed by method and application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114891822A true CN114891822A (en) | 2022-08-12 |
CN114891822B CN114891822B (en) | 2024-04-05 |
Family
ID=82729249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210762108.9A Active CN114891822B (en) | 2022-06-29 | 2022-06-29 | Construction method of high-yield gamma-linolenic acid mucor circinelloides recombinant bacterium, recombinant bacterium constructed by method and application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114891822B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101400798A (en) * | 2006-02-21 | 2009-04-01 | 巴斯福植物科学有限公司 | Preparation of polyunsaturated fatty acids |
CN107236679A (en) * | 2017-04-27 | 2017-10-10 | 广州弘宝元生物科技有限公司 | A kind of high yield unrighted acid recombinant strain and its construction method |
CN110373437A (en) * | 2018-12-11 | 2019-10-25 | 山东理工大学 | A kind of building and its fermentation technique for producing parinaric acid and rolling up branch Mucor cell factory |
CN110373436A (en) * | 2018-12-11 | 2019-10-25 | 山东理工大学 | A kind of construction method and fermentation technique producing bishomo-γ-linolenic acid volume branch Mucor cell factory |
CN111471602A (en) * | 2020-04-30 | 2020-07-31 | 山东理工大学 | Construction method and application of mucor circinelloides engineering strain for efficiently synthesizing gamma-linolenic acid by using cellulose |
CN112410357A (en) * | 2020-05-26 | 2021-02-26 | 山东理工大学 | Construction method of non-de novo synthesized high-yield mucor circinelloides recombinant bacteria, recombinant bacteria constructed by method and application |
-
2022
- 2022-06-29 CN CN202210762108.9A patent/CN114891822B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101400798A (en) * | 2006-02-21 | 2009-04-01 | 巴斯福植物科学有限公司 | Preparation of polyunsaturated fatty acids |
CN107236679A (en) * | 2017-04-27 | 2017-10-10 | 广州弘宝元生物科技有限公司 | A kind of high yield unrighted acid recombinant strain and its construction method |
CN110373437A (en) * | 2018-12-11 | 2019-10-25 | 山东理工大学 | A kind of building and its fermentation technique for producing parinaric acid and rolling up branch Mucor cell factory |
CN110373436A (en) * | 2018-12-11 | 2019-10-25 | 山东理工大学 | A kind of construction method and fermentation technique producing bishomo-γ-linolenic acid volume branch Mucor cell factory |
US20210102225A1 (en) * | 2018-12-11 | 2021-04-08 | Shandong University Of Technology | Construction of mucor circinelloides cell factory for producing stearidonic acid and fermentation technology thereof |
CN111471602A (en) * | 2020-04-30 | 2020-07-31 | 山东理工大学 | Construction method and application of mucor circinelloides engineering strain for efficiently synthesizing gamma-linolenic acid by using cellulose |
CN112410357A (en) * | 2020-05-26 | 2021-02-26 | 山东理工大学 | Construction method of non-de novo synthesized high-yield mucor circinelloides recombinant bacteria, recombinant bacteria constructed by method and application |
Non-Patent Citations (1)
Title |
---|
RAWISARA RUENWAI等: "Oxygen-induced expression of Δ6-, Δ9- and Δ12-desaturase genes modulates fatty acid composition in Mucor rouxii", APPL MICROBIOL BIOTECHNOL, vol. 86, pages 327 - 334, XP019799889 * |
Also Published As
Publication number | Publication date |
---|---|
CN114891822B (en) | 2024-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107709540B (en) | Pichia kudriavzevii NG7 microorganism and application thereof | |
KR101576186B1 (en) | Kluyveromyces marxianus deficient in the ethanol fermentation and use thereof | |
CN107815424B (en) | Yarrowia lipolytica gene engineering bacterium for producing limonene and application thereof | |
CN110157654B (en) | Bacillus natto recombinant strain and construction method and application thereof | |
US11345937B2 (en) | Construction of Mucor circinelloides cell factory for producing stearidonic acid and fermentation technology thereof | |
US11414650B2 (en) | Construction method of Mucor circinelloides cell factory for producing dihomo-gamma-linolenic acid and fermentation technology | |
CN112410357B (en) | Construction method of non-de novo synthesized high-yield mucor circinelloides recombinant bacteria, recombinant bacteria constructed by method and application | |
CN102016024A (en) | Yeast mutant and substance production method using the same | |
CN105647822B (en) | Recombinant mortierella alpina for overexpression of omega-3 desaturase from phytophthora parasitica as well as construction method and application thereof | |
CN111471602B (en) | Construction method and application of mucor circinelloides engineering strain for efficiently synthesizing gamma-linolenic acid by using cellulose | |
CN110117601A (en) | Grifola frondosus glucan synthase, its encoding gene and application | |
CN108359628B (en) | Gene engineering bacterium for producing polyhydroxyalkanoate by using acetic acid and propionic acid and construction method and application thereof | |
CN113817782B (en) | Full biosynthesis method of pimelic acid | |
CN113604472B (en) | CRISPR/Cas gene editing system applied to Trichoderma reesei | |
CN109722436A (en) | The carrier of the seamless editor of genome based on CRISPR-Cas9 and application | |
CN114958636B (en) | Recombinant yarrowia lipolytica capable of producing punica granatum at high yield as well as construction method and application thereof | |
CN114891822B (en) | Construction method of high-yield gamma-linolenic acid mucor circinelloides recombinant bacterium, recombinant bacterium constructed by method and application | |
EP2576799B1 (en) | Production of fatty acids by heterologous expression of gene clusters from myxobacteria | |
JP2021106614A (en) | Method for producing organic acid | |
CN109370969B (en) | Application of recombinant Klebsiella in preparation of 1, 3-propylene glycol | |
Li et al. | Overexpression of an inulinase gene in an oleaginous yeast, Aureobasidium melanogenum P10, for efficient lipid production from inulin | |
CN111304104A (en) | Recombinant yarrowia lipolytica for heterologous synthesis of betulinic acid and construction method thereof | |
CN106801063B (en) | Construction method of engineering escherichia coli with changed form, engineering escherichia coli and application | |
CN113122461A (en) | Single cell protein producing strain and its application | |
JPWO2018051916A1 (en) | Method of producing organic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |